Amyris IPO looms: deal or no deal?
In California, Amyris Biotechnologies is in the final stages leading to the pricing of its IPO, and just two questions remain, but they are big ones: 1. How will Amyris price if at all, and begin public trading. 2. Is it a safe buy, or a long shot? Here’s what the Digest’s editors and sources […]









